Couples Therapy: VC Discusses Challenges In Companion Diagnostic-Biopharma Relationships
This article was originally published in The Gray Sheet
Executive Summary
Companion diagnostic firms facing skeptical partners in big pharma need to focus on ways of establishing the value of their test to payers and patients, Third Rock Ventures’ Mark Levin told the Personalized Medicine Coalition.